Acylated indanyl amines and their use as pharmaceuticals

Details for Australian Patent Application No. 2002253010 (hide)

Owner Sanofi-Aventis Deutschland GmbH

Inventors Walser, Armin; Safarova, Alena; Schoenafinger, Karl; Strobel, Hartmut; Suzuki, Teri; Dharanipragada, Ramalinga, M.; Wohlfart, Paulus

Agent Watermark

Pub. Number AU-B-2002253010

PCT Pub. Number WO2002/064545

Priority 01 102 850.3 13.02.01 EP

Filing date 12 February 2002

Wipo publication date 28 August 2002

Acceptance publication date 28 February 2008

International Classifications

C07C 233/04 (2006.01) Carboxylic acid amides

A61K 9/02 (2006.01) Medicinal preparations characterised by special physical form - Suppositories

A61K 9/06 (2006.01) Medicinal preparations characterised by special physical form - Ointments

A61K 9/08 (2006.01) Medicinal preparations characterised by special physical form - Solutions

A61K 9/10 (2006.01) Medicinal preparations characterised by special physical form - Dispersions

A61K 9/12 (2006.01) Medicinal preparations characterised by special physical form - Aerosols

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 9/28 (2006.01) Medicinal preparations characterised by special physical form - Dragees

A61K 9/50 (2006.01) Medicinal preparations characterised by special physical form - Microcapsules

A61K 9/72 (2006.01) Medicinal preparations characterised by special physical form - for smoking or inhaling

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 31/166 (2006.01) - having the carbon atom of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol

A61K 31/18 (2006.01) - Sulfonamides

A61K 31/194 (2006.01)

A61K 31/222 (2006.01)

A61K 31/341 (2006.01) - not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine

A61K 31/343 (2006.01) - condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone

A61K 31/357 (2006.01) - having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel

A61K 31/36 (2006.01)

A61K 31/381 (2006.01) - having five-membered rings

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/404 (2006.01)

A61K 31/415 (2006.01) - 1,2-Diazoles

A61K 31/4184

Event Publications

20 February 2003 Application Open to Public Inspection

  Published as AU-B-2002253010

25 September 2003 Amendment Made

  The nature of the amendment is: Add the co-inventor Schoenafinger, Karl

22 December 2005 Assignment before Grant

  Aventis Pharma Deutschland GmbH The application has been assigned to Sanofi-Aventis Deutschland GmbH

28 February 2008 Application Accepted

  Published as AU-B-2002253010

26 June 2008 Standard Patent Sealed

2 April 2009 Corrigenda

  Applications Accepted - Name Index Under the name Sanofi-Aventis Deutschland GmbH, Application No. 2002253010, under INID (72) correct the co-inventor name to read Walser, Armin.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002253011-CIGARETTE PACKET

2002253009-4-fluoro-N-indan-2-yl benzamide and its use as pharmaceutical